Search
H.C. Wainwright & Co.'s President of Capital Markets' Richard Gormley discusses the current environment for biotech
From the 2025 H.C. Wainwright Global Investor Conference, we discuss interest rates, M&A, data readouts, and more. Coverage brought to...
Sep 8
Verastem's CEO Dan Paterson discusses the launch of the Avmapki Fakzynja Co-Pack for KRAS-mutated recurrent low-grade serous ovarian cancer, and other pipeline projects
He discusses the launch of this combination, which was an accelerated approval, and arrived a couple of months sooner than the scheduled...
Sep 8
Humacyte CEO Laura Niklason updates us on the early days of the launch of Symvess, the company's bioengineered blood vessel product
She describes the work the company is doing with hospitals and the military to grow uptake as the company launches the product. Plus,...
Sep 8
Syndax's CEO talks about the company's two new launches (Revuforj and Niktimvo), both of which are tracking ahead of expectations
Michael Metzger describes the uptake of the therapies, both of which were approved in the second half of last year, and highlights a...
Sep 8
H.C. Wainwright & Co. CEO Mark Kaplan sees a warming up of the fundraising environment for biotech over the coming months
Kicking off BiotechTV's coverage of the 2025 HCW Global Investor Conference in New York, the new CEO of H.C. Wainwright gives his take on...
Sep 8
Biotech veteran Harvey Berger was named Chairman & CEO of Arena BioWorks today - he describes how 'foraging to focusing' will be the name of the game
Dr. Berger, whose experience in biotech goes back decades, including founding and running ARIAD for 25 years, is taking over this company...
Sep 8
Stevenage, UK based NRG Therapeutics raised a $67M series B today to advance its aim to restore mitochondrial function and slow the progression of neurodegenerative diseases like Parkinson's and ALS
CEO Neil Miller walks us through the hypothesis of how toxic proteins created by neurodegenerative diseases enter and damage the...
Sep 8
Fairtility has received FDA clearance on its AI-based embryo assessment tool for IVF, CHLOE Blast, that helps embryologists with embryo assessments
Co-Founder and CEO Eran Eshed describes the unmet need and how CHLOE Blast analyzes images from a time-laps incubator.
Sep 7
Precision for Medicine CMO Harpreet Singh and Repertoire Immune Medicines CMO Robert Andtbacka discuss oncology clinical trial design, life on the biotech side, and advice for other CMOs
In a wide-ranging discussion, Dr. Singh and Dr. Andtbacka reflect on the success of the immunotherapy field and the cancer centers that...
Sep 5
Biotech CEO Sisterhood: Hanadie Yousef leads Juvena Therapeutics, a company developing protein based therapeutics that are tissue restorative for muscle and metabolic diseases
She describes the process of how the company's computing platform sorts through proteins that are secreted by stem cells and screens them...
Sep 4
Biotech CEO Sisterhood: Catherine Pickering is leading iOnctura, which is focused on solving the problem of cancer resistance both at the tumor and around its environment
She discusses the approach and the company's lead program, which targets PI3Kδ. Plus, and autotaxin program for cancer and TGF-β.
Sep 4
Biotech CEO Sisterhood: Sheila Gujrathi is an experienced leader in biotech, a co-founder of the Biotech CEO Sisterhood, and has a new book coming out next month
Dr. Gujrathi describes the beginning of the Sisterhood, discusses her new book, "The Mirror Effect," and shares her take on biotech and...
Sep 4
Biotech CEO Sisterhood: Stacy Blain is the Founder and CEO of Concarlo Therapeutics, which is the first company to target CDK4/6-driven cell proliferation and CDK2-driven resistance
She describes the unmet need for patients who no longer respond to the large CDK4/6 class of medicines, and the decades of work she has...
Sep 4
Biotech CEO Sisterhood: Catherine Sabatos-Peyton is leading Larkspur Biosciences, a company targeting cancer cell fitness
She describes the work the company is doing, which has a lead program targeting PIP4K2C and is scheduled to be in the clinic later this...
Sep 4
N-Power Medicine launched what it is calling the 'Industry’s First Prospective External Control Arm Platform' for cancer trials - Mark Lee, CEO and a medical oncologist, explains why and how it works
He describes how the idea is to cut down on control arm overlap used in numerous trials. If successful, it might free up space and...
Sep 2
Two leaders from the Harvard Biotech Club talk about their experience in the club, its new podcast, The Pulse, and an upcoming career fair on September 19th
Yossef Baidi and Fang Xie describe how getting involved in the club has benefited them, and the idea behind their new podcast (George...
Sep 2
Cytokinetics' CEO Robert Blum discusses the result of the MAPLE-HCM study of aficamten, and other learnings from the European Society of Cardiology Congress 2025
He shares what he believes the takeaways are from MAPLE-HCM, which studied aficamten vs a beta blocker in symptomatic obstructive...
Sep 2
John Maraganore and Clive Meanwell are launching Corsera Health out of stealth - which, through a combo of predictive diagnostics and an RNAi targeting PCSK9 and angiotensinogen, aims extend lifespans
Launched publicly today, and funded with $50M at this point, Corsera Health hopes to target those who are most at risk for...
Sep 2
Biotech CEO Sisterhood: Kiran Mazumdar-Shaw, builder of India's leading biotech enterprise and a pioneer in the development of biologics and biosimilars, shares her story and learnings from business
Interviewed by Sisterhood editorial board member Sheila Gujrathi, Kiran Mazumdar-Shaw describes her beginnings in designing enzymes, and...
Sep 2
The CEO of Tennr, which raised a $101M series C earlier this summer, explains how the company's platform uses large language models to make the patient referral process to specialists more efficient
Trey Holterman describes how Tennr is trying to fix this process which relies on significant unstructured data and has traditional leads...
Aug 28
.png){kind=logo}
